These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Neurodegenerative movement disorders: the contribution of functional imaging. Piccini P Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543 [TBL] [Abstract][Full Text] [Related]
7. Radiopharmaceuticals for single-photon emission computed tomography brain imaging. Kung HF; Kung MP; Choi SR Semin Nucl Med; 2003 Jan; 33(1):2-13. PubMed ID: 12605353 [TBL] [Abstract][Full Text] [Related]
8. Current status and future challenges of brain imaging with (18)F-DOPA PET for movement disorders. Calabria FF; Calabria E; Gangemi V; Cascini GL Hell J Nucl Med; 2016; 19(1):33-41. PubMed ID: 26929938 [TBL] [Abstract][Full Text] [Related]
9. New developments of dopaminergic imaging in Parkinson's disease. Varrone A; Halldin C Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):68-82. PubMed ID: 22460161 [TBL] [Abstract][Full Text] [Related]
11. Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson's disease research. Seibyl J; Jennings D; Tabamo R; Marek K Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):215-21. PubMed ID: 16010256 [TBL] [Abstract][Full Text] [Related]
12. New Imaging Markers for Movement Disorders. Ghadery C; Strafella AP Curr Neurol Neurosci Rep; 2018 Apr; 18(5):22. PubMed ID: 29616343 [TBL] [Abstract][Full Text] [Related]
13. Molecular imaging update: advances in MI of the brain. VanBrocklin H; Herscovitch P J Nucl Med; 2007 May; 48(5):24N, 29N. PubMed ID: 17475948 [No Abstract] [Full Text] [Related]
15. Tracer development and hybrid imaging. Yang DJ; Kim EE Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1001-2. PubMed ID: 16086160 [No Abstract] [Full Text] [Related]
17. The molecular basis of dopaminergic brain imaging in Parkinson's disease. Seibyl J; Russell D; Jennings D; Marek K Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):4-16. PubMed ID: 22460156 [TBL] [Abstract][Full Text] [Related]
18. The future of SPECT in a time of PET. Jansen FP; Vanderheyden JL Nucl Med Biol; 2007 Oct; 34(7):733-5. PubMed ID: 17921025 [TBL] [Abstract][Full Text] [Related]
19. Evaluating pathology in the brain with nuclear medicine. Silverman DH Semin Nucl Med; 2008 Jul; 38(4):225-6. PubMed ID: 18514078 [No Abstract] [Full Text] [Related]
20. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease. Seibyl J; Jennings D; Tabamo R; Marek K Minerva Med; 2005 Oct; 96(5):353-64. PubMed ID: 16227950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]